Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of
those modalities in the characterization of therapy response and/or emergence of resistance.
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:http://grants.nih.gov/grants/guide/pa-files/PAR-21-290.html
Additional Information of Eligibility:Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Full Opportunity Web Address:http://grants.nih.gov/grants/guide/pa-files/PAR-21-290.htmlContact: Agency Email Description: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email: Date Posted: 2021-07-22
Application Due Date: Archive Date: 2024-10-13